pravastatin has been researched along with Kidney Failure, Chronic in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukubo, T; Izumi, S; Kimura, A; Minegaki, T; Nishiguchi, K; Saiki, T; Tachiki, H; Tsujimoto, M; Uchiyama, H; Yamakawa, T; Yoshida, T; Yuki, E | 1 |
| Ahn, CM; Chang, HJ; Choi, D; Chun, KH; Ha, JW; Hong, GR; Hong, MK; Jang, Y; Kang, M; Kang, SM; Kim, BK; Kim, JS; Ko, YG; Lee, CJ; Lee, SH; Oh, J; Park, S; Roh, JW; Shim, CY | 1 |
| Chertow, GM; Erickson, KF; Garber, AM; Goldhaber-Fiebert, JD; Japa, S; Owens, DK | 1 |
| Jha, V; Modi, GK | 1 |
| Baimbridge, C; Ciocon, JO; Cuyjet, AB; Dart, RA; Davis, BR; Einhorn, PT; Ford, CE; Gordon, D; Hartney, TJ; Holtzman, J; Julian Haywood, L; Margolis, KL; Mathis, DE; Oparil, S; Probstfield, JL; Simpson, LM; Stokes, JD; Wiegmann, TB; Williamson, JD | 1 |
| Angel-Zúñiga, JR; Cortés-Sanabria, L; Cueto-Manzano, AM; Martínez-Ramírez, HR; Ornelas-Carrillo, G; Rojas-Campos, E | 1 |
| Cadnapaphornchai, MA | 1 |
| Baimbridge, C; Barzilay, J; Basile, JN; Davis, BR; Henriquez, MA; Huml, A; Kopyt, N; Louis, GT; Pressel, SL; Rahman, M; Rosendorff, C; Sastrasinh, S; Stanford, C | 1 |
| Hirao, K; Mizuno, K; Nakamura, H; Ohashi, Y; Uchida, Y; Yoshida, T | 1 |
| Bouquié, R; Dailly, E; Deslandes, G; Haloun, A; Jolliet, P; Renaud, C | 1 |
| Furukubo, T; Hatozaki, D; Izumi, S; Minegaki, T; Nishiguchi, K; Shima, D; Tsujimoto, M; Yamakawa, T; Yokota, H | 1 |
| Ito, T; Kushihata, S; Masaki, T; Nishida, Y; Oda, H; Taniguchi, Y; Yamakido, M; Yorioka, N | 1 |
| Curhan, G; Kiberd, B; Moyé, L; Sacks, FM; Tonelli, M | 1 |
| Cole, T; Curhan, GC; Moyé, L; Sacks, FM; Tonelli, M | 1 |
| Schück, O; Stollová, M; Teplan, V; Vítko, S | 1 |
| Curhan, G; Jhangri, GS; Pfeffer, M; Sacks, F; Tonelli, M | 1 |
| Davidson, M | 1 |
| Deray, G; Isnard-Bagnis, C; Karie, S; Launay-Vacher, V | 1 |
| Nanayakkara, PW; Scheffer, PG; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Dorp, W; van Guldener, C; van Ittersum, FJ | 1 |
| Blom, HJ; Kiefte-de Jong, JC; Kok, RM; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; ter Wee, PM; van Guldener, C; van Ittersum, FJ | 1 |
| Wanner, C | 1 |
| DerFler, K | 1 |
| Mimura, K; Yukawa, S | 1 |
4 review(s) available for pravastatin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.
Topics: Aged; Cost-Benefit Analysis; Decision Support Techniques; Disease Progression; Drug Costs; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Markov Chains; Myocardial Infarction; Pravastatin; Primary Prevention; Quality-Adjusted Life Years; Rhabdomyolysis; Risk; Sex Factors; Stroke; United States | 2013 |
Autosomal dominant polycystic kidney disease in children.
Topics: Blood Pressure; Child; Child, Preschool; Diet, Sodium-Restricted; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Polycystic Kidney, Autosomal Dominant; Pravastatin; Prognosis; Renal Dialysis; Ultrasonography | 2015 |
Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
Topics: Atorvastatin; Comorbidity; Dyslipidemias; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney Failure, Chronic; Kidney Transplantation; Lovastatin; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2005 |
[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Dyslipidemias; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Graft Rejection; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Pravastatin; Primary Prevention; Prospective Studies; Proteinuria; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors | 2006 |
9 trial(s) available for pravastatin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
Topics: Aged; Anticholesteremic Agents; Black People; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Patient Compliance; Pravastatin; Risk Factors; Treatment Outcome | 2013 |
Anti-inflammatory interventions in end-stage kidney disease: a randomized, double-blinded, controlled and crossover clinical trial on the use of pravastatin in continuous ambulatory peritoneal dialysis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Female; Humans; Inflammation; Kidney Failure, Chronic; Male; Mexico; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Placebos; Pravastatin; Treatment Outcome; Young Adult | 2013 |
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Topics: Aged; Anticholesteremic Agents; Cholesterol; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypercholesterolemia; Hypertension; Incidence; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Pravastatin; Treatment Outcome | 2008 |
Pravastatin and cardiovascular risk in moderate chronic kidney disease.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Kidney Failure, Chronic; Male; Middle Aged; Pravastatin; Risk | 2009 |
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.
Topics: Aged; Cardiovascular Diseases; Creatinine; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Patient Compliance; Pravastatin; Stroke | 2003 |
Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease.
Topics: Aged; Creatine Kinase; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Myocardial Infarction; Pravastatin; Proteinuria; Severity of Illness Index; Single-Blind Method | 2003 |
Biomarkers of inflammation and progression of chronic kidney disease.
Topics: Adult; Aged; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Disease Progression; Etanercept; Female; Humans; Hyperlipidemias; Immunoglobulin G; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Myocardial Infarction; Pravastatin; Receptors, Tumor Necrosis Factor | 2005 |
Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxid
Topics: Administration, Oral; Carotid Artery, Common; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Pravastatin; Pyridoxine; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Ultrasonography; Vitamin E; Vitamins | 2007 |
Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
Topics: Adult; Carotid Arteries; DNA Methylation; Double-Blind Method; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Leukocytes; Male; Middle Aged; Pravastatin; Tunica Intima; Vitamin B Complex; Vitamin E | 2008 |
11 other study(ies) available for pravastatin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes.
Topics: Biological Transport; Cells, Cultured; HEK293 Cells; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Liver-Specific Organic Anion Transporter 1; Pravastatin; Solute Carrier Organic Anion Transporter Family Member 1B3; Toxins, Biological; Uremia | 2019 |
PRavastatin Versus FlUVastatin After Statin Intolerance: The PRUV-Intolerance Study With Propensity Score Matching.
Topics: Aged; Biomarkers; Creatine Kinase; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Pravastatin; Propensity Score; Retrospective Studies; Risk Factors | 2019 |
Cardiovascular disease: The price of a QALY--cost-effectiveness of statins in CKD.
Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Myocardial Infarction; Pravastatin; Rhabdomyolysis; Stroke | 2013 |
Colchicine-induced rhabdomyolysis in a heart/lung transplant patient with concurrent use of cyclosporin, pravastatin, and azithromycin.
Topics: Adult; Anti-Bacterial Agents; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Colchicine; Cyclosporine; Cystic Fibrosis; Drug Interactions; Gout; Gout Suppressants; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Multiple Organ Failure; Pravastatin; Rhabdomyolysis | 2011 |
Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.
Topics: Biological Transport; Caco-2 Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Kidney Failure, Chronic; Liver; Liver Neoplasms; Liver-Specific Organic Anion Transporter 1; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Pravastatin; Renal Dialysis; RNA, Messenger; Uremia | 2012 |
Lipid-lowering therapy and coagulation/fibrinolysis parameters in patients on peritoneal dialysis.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Coagulation Factors; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Fibrinolysis; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Platelet Aggregation Inhibitors; Pravastatin; Statistics, Nonparametric; Treatment Outcome | 2000 |
Summaries for patients. Treating cholesterol in patients with mild kidney disease.
Topics: Aged; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Pravastatin | 2003 |
Obesity and hyperhomocysteinaemia after kidney transplantation.
Topics: Adult; Aged; Cohort Studies; Combined Modality Therapy; Diet Therapy; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperhomocysteinemia; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Obesity; Postoperative Complications; Pravastatin; Probability; Prospective Studies; Risk Assessment; Treatment Outcome; Vitamin B 6 | 2003 |
HMG-CoA reductase inhibitor treatment in renal insufficiency.
Topics: Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lovastatin; Pravastatin; Rhabdomyolysis; Simvastatin | 1996 |
[Disorders of lipid metabolism and renal failure--what is cause, what is sequelae?].
Topics: Anticholesteremic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney Failure, Chronic; Kidney Transplantation; Postoperative Complications; Pravastatin | 1996 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidney Failure, Chronic; Niceritrol; Pantetheine; Pravastatin; Probucol; Vitamin E | 1991 |